Medtronic bone graft has limited benefit, may cause harm: reviews
By Deena Beasley (Reuters) - Two long-awaited independent reviews of a controversial Medtronic Inc bone growth product show it works...
Read More »Health News
Subscribe to the Health News feed.-
-
Wait-and-see may be best for early prostate cancer
By Genevra Pittman NEW YORK (Reuters Health) - Watching and routinely examining men with early, slow-growing prostate cancer is more...
Read More » -
Blood tests could detect sexually-transmitted oral cancers
By Kate Kelland LONDON (Reuters) - Antibodies to a high-risk type of a virus that causes mouth and throat cancers when transmitted v...
Read More » -
Arizona Governor Jan Brewer signs Medicaid expansion
By David Schwartz PHOENIX (Reuters) - Arizona's Republican Governor Jan Brewer signed a law on Monday to expand Medicaid, embracing ...
Read More » -
Eating more red meat tied to higher diabetes risk
By Andrew M. Seaman NEW YORK (Reuters Health) - Increasing the number of hamburgers and other red meat people eat on a daily basis i...
Read More » -
Falling toilet seats: Rare but growing risk for boys
By Andrew M. Seaman NEW YORK (Reuters Health) - Ouch: Boys know that toilet seats are an occupational hazard of potty training, but ...
Read More » -
Jury finds no negligence in trial over man's 8-month erection
By Myles Miller WILMINGTON, Delaware (Reuters) - A jury on Monday cleared a doctor of negligence in a lawsuit filed by a Delaware tr...
Read More » -
Niche drugmaker ViroPharma attracts takeover interest: sources
By Jessica Toonkel NEW YORK (Reuters) - ViroPharma Inc, a drug maker specializing in rare diseases, is attracting preliminary acquis...
Read More » -
Evidence thin on osteopathic manipulation for kids
By Genevra Pittman NEW YORK (Reuters Health) - There is no clear evidence that osteopathic manipulation helps treat kids and teenage...
Read More » -
Supreme court says FTC can sue over deals that delay generic drug sales
By Lawrence Hurley and Diane Bartz WASHINGTON (Reuters) - The Supreme Court ruled on Monday regulators can challenge deals between b...
Read More »